FDA
-
-
-
-
-
-
-
Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
-
-
-
-
-
-
-
Mydecine Reports Financial Results for the Year Ended December 2022
-
-
-
-
-
-
-
Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study
-
-
-
-
-
-
-
Mydecine Completes Spin-Out of U.S. Cannabis Assets
-
-
-
-
-
-
-
Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials
-
-
-
-
323,754 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

